This elective unit will focus on neuropsychopharmacology as a tool for characterizing brain pathways and as a treatment for brain disorders. Students will be introduced to basic principles of pharmacology governing drug binding and metabolism that underlie the rationale for drug design. Links between brain circuitry and phenomenology of various brain disorders including chronic pain, anxiety and dementia will be examined to provide a rationale for chosen drug targets. Students will also examine the relationship between dosage, specificity and negative side effects of such drugs. There will be the opportunity critically to examine current directions in neuropharmacology research, the role of the pharmaceutical industry and potential new pathways for future drug design.
Unit details and rules
Academic unit | Central Clinical School |
---|---|
Credit points | 6 |
Prerequisites
?
|
None |
Corequisites
?
|
None |
Prohibitions
?
|
None |
Assumed knowledge
?
|
None |
Available to study abroad and exchange students | No |
Teaching staff
Coordinator | Eryn Werry, eryn.werry@sydney.edu.au |
---|